Bistability in glycolysis pathway as a physiological switch in energy metabolism

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Mulukutla, Bhanu Chandra ^a   Yongky, Andrew ^a   Daoutidis, Prodromos ^a   Hu, Wei Shou ^a  

^a University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTOKINASE; FRUCTOSE 2,6 BISPHOSPHATE; FRUCTOSE BISPHOSPHATASE; FRUCTOSE BISPHOSPHATE ALDOLASE; NICOTINAMIDE ADENINE DINUCLEOTIDE; PHOSPHOTRANSFERASE; PYRUVATE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; FRUCTOSE PHOSPHATE; FRUCTOSE-6-PHOSPHATE; ISOENZYME;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BISTABILITY; CARBOHYDRATE METABOLISM; CELL METABOLISM; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; FEEDBACK SYSTEM; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCOLYSIS; HORMONAL REGULATION; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RESPONSE TIME; STEADY STATE; BIOLOGICAL MODEL; HELA CELL LINE; HUMAN; KINETICS; METABOLISM;

ENERGY METABOLISM; FRUCTOSEPHOSPHATES; GLYCOLYSIS; HELA CELLS; HUMANS; ISOENZYMES; KINETICS; MODELS, BIOLOGICAL; PHOSPHOFRUCTOKINASES; PYRUVATE KINASE;

EID: 84902590385     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098756     Document Type: Article

References (61)

1. Warburg O (1956) On the origin of cancer cells. Science 123: 309-314.
2. Folmes CD, Dzeja PP, Nelson TJ, Terzic A (2012) Metabolic plasticity in stem cell homeostasis and differentiation. Cell Stem Cell 11: 596-606.
3. Zhang J, Nuebel E, Daley GQ, Koehler CM, Teitell MA (2012) Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell 11: 589-595.
4. Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, et al. (2011) Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metab 14: 264-271.
5. Locasale JW, Cantley LC (2011) Metabolic flux and the regulation of mammalian cell growth. Cell Metab 14: 443-451.
6. Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer 11: 325-337.
7. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
8. Mulukutla BC, Khan S, Lange A, Hu WS (2010) Glucose metabolism in mammalian cell culture: new insights for tweaking vintage pathways. Trends Biotechnol 28: 476-484.
9. Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, et al. (2001) PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate. Trends Biochem Sci 26: 30-35. (Pubitemid 32124707)
10. Wilson JE (2003) Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 206: 2049-2057.
11. Yamada K, Noguchi T (1999) Nutrient and hormonal regulation of pyruvate kinase gene expression. Biochem J 337 (Pt 1): 1-11. (Pubitemid 29039075)
12. Vora S, Oskam R, Staal GE (1985) Isoenzymes of phosphofructokinase in the rat. Demonstration of the three non-identical subunits by biochemical, immunochemical and kinetic studies. Biochem J 229: 333-341. (Pubitemid 15232041)
13. Van Schaftingen E, Jett MF, Hue L, Hers HG (1981) Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc Natl Acad Sci U S A 78: 3483-3486. (Pubitemid 11059314)
14. Reinhart GD, Lardy HA (1980) Rat liver phosphofructokinase: kinetic activity under near-physiological conditions. Biochemistry 19: 1477-1484.
15. Yaney GC, Schultz V, Cunningham BA, Dunaway GA, Corkey BE, et al. (1995) Phosphofructokinase isozymes in pancreatic islets and clonal beta-cells (INS-1). Diabetes 44: 1285-1289.
16. Schulze A, Ros S (2013) Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism. Cancer and Metabolism 1: 10.
17. Kretschmer M, Hofmann E (1984) Inhibition of rat liver phosphofructokinase-2 by phosphoenolpyruvate and ADP. Biochem Biophys Res Commun 124: 793-796. (Pubitemid 15219694)
18. Tominaga N, Tsujikawa T, Minami Y, Wu RF, Watanabe F, et al. (1997) Effect of replacement of the amino and the carboxyl termini of rat testis fructose 6-phosphate, 2-kinase:fructose 2,6-bisphosphatase with those of the liver and heart isozymes. Arch Biochem Biophys 347: 275-281. (Pubitemid 27492800)
19. Manes NP, El-Maghrabi MR (2005) The kinase activity of human brain 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is regulated via inhibition by phosphoenolpyruvate. Arch Biochem Biophys 438: 125-136. (Pubitemid 40798012)
20. Morgan HP, O'Reilly FJ, Wear MA, O'Neill JR, Fothergill-Gilmore LA, et al. (2013) M2 pyruvate kinase provides a mechanism for nutrient sensing and regulation of cell proliferation. Proc Natl Acad Sci U S A 110: 5881-5886.
21. Keller KE, Tan IS, Lee YS (2012) SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions. Science 338: 1069-1072.
22. Chaneton B, Hillmann P, Zheng L, Martin AC, Maddocks OD, et al. (2012) Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491: 458-462.
23. Ward PS, Thompson CB (2012) Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21: 297-308.
24. Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13: 472-482. (Pubitemid 351766797)
25. Levine AJ, Puzio-Kuter AM (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330: 1340-1344.
26. Majewski N, Nogueira V, Bhaskar P, Coy PE, Skeen JE, et al. (2004) Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 16: 819-830. (Pubitemid 39586539)
27. Gottlob K, Majewski N, Kennedy S, Kandel E, Robey RB, et al. (2001) Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev 15: 1406-1418. (Pubitemid 32524647)
28. Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, et al. (2008) The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452: 230-233. (Pubitemid 351380249)
29. Hitosugi T, Kang S, Vander Heiden MG, Chung TW, Elf S, et al. (2009) Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal 2: ra73.
30. Ishibashi H, Cottam GL (1978) Glucagon-stimulated phosphorylation of pyruvate kinase in hepatocytes. J Biol Chem 253: 8767-8771. (Pubitemid 9104662)
31. Xiong W, Ferrell JE Jr (2003) A positive-feedback-based bistable 'memory module' that governs a cell fate decision. Nature 426: 460-465. (Pubitemid 37490134)
32. Yao G, Lee TJ, Mori S, Nevins JR, You L (2008) A bistable Rb-E2F switch underlies the restriction point. Nat Cell Biol 10: 476-482.
33. Thomson M, Gunawardena J (2009) Unlimited multistability in multisite phosphorylation systems. Nature 460: 274-277.
34. Tornheim K, Lowenstein JM (1976) Control of phosphofructokinase from rat skeletal muscle. Effects of fructose diphosphate, AMP, ATP, and citrate. J Biol Chem 251: 7322-7328.
35. Bosca L, Aragon JJ, Sols A (1982) Specific activation by fructose 2,6-bisphosphate and inhibition by P-enolpyruvate of ascites tumor phosphofructokinase. Biochem Biophys Res Commun 106: 486-491. (Pubitemid 13214639)
36. Mulquiney PJ, Kuchel PW (1999) Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: equations and parameter refinement. Biochem J 342 Pt 3: 581-596. (Pubitemid 29452643)
37. Mulukutla BC, Gramer M, Hu WS (2012) On metabolic shift to lactate consumption in fed-batch culture of mammalian cells. Metab Eng 14: 138-149.
38. Albe KR, Butler MH, Wright BE (1990) Cellular concentrations of enzymes and their substrates. J Theor Biol 143: 163-195. (Pubitemid 20141560)
39. Kitajima S, Sakakibara R, Uyeda K (1984) Kinetic studies of fructose 6-phosphate,2-kinase and fructose 2,6-bisphosphatase. J Biol Chem 259: 6896-6903. (Pubitemid 14078987)
40. Kretschmer M, Schellenberger W, Hofmann E (1985) Quasi-stationary concentrations of fructose-2,6-bisphosphate in the phosphofructokinase-2/ fructose-2,6-bisphosphatase cycle. Biochem Biophys Res Commun 131: 899-904. (Pubitemid 16224976)
41. Yan L, Yang M, Guo H, Yang L, Wu J, et al. (2013) Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol 20: 1131-1139.
42. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, et al. (2011) Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev 25: 1915-1927.
43. Mouse EC, Stamatoyannopoulos JA, Snyder M, Hardison R, Ren B, et al. (2012) An encyclopedia of mouse DNA elements (Mouse ENCODE). Genome Biol 13: 418.
44. van Heerden JH, Wortel MT, Bruggeman FJ, Heijnen JJ, Bollen YJ, et al. (2014) Lost in transition: start-up of glycolysis yields subpopulations of nongrowing cells. Science 343: 1245114.
45. Clower CV, Chatterjee D, Wang Z, Cantley LC, Vander Heiden MG, et al. (2010) The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc Natl Acad Sci US A 107: 1894-1899.
46. David CJ, Chen M, Assanah M, Canoll P, Manley JL (2010) HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature 463: 364-368.
47. Zancan P, Sola-Penna M, Furtado CM, Da Silva D (2010) Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol Genet Metab 100: 372-378.
48. Moreno-Sanchez R, Marin-Hernandez A, Gallardo-Perez JC, Quezada H, Encalada R, et al. (2012) Phosphofructokinase type 1 kinetics, isoform expression, and gene polymorphisms in cancer cells. J Cell Biochem 113: 1692-1703.
49. Kurata N, Matsushima T, Sugimura T (1972) Multiple forms of phosphofructokinase in rat tissues and rat tumors. Biochem Biophys Res Commun 48: 473-479.
50. Desai S, Ding M, Wang B, Lu Z, Zhao Q, et al. (2013) Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers. Oncotarget. Available: http://www.impactjournals.com/oncotarget/index. php?journal=oncotarget&page=article&op=view&path%5B%5D=1159.
51. Marin-Hernandez A, Gallardo-Perez JC, Ralph SJ, Rodriguez-Enriquez S, Moreno-Sanchez R (2009) HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem 9: 1084-1101.
52. Chesney J (2006) 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis. Curr Opin Clin Nutr Metab Care 9: 535-539.
53. Gui DY, Lewis CA, Vander Heiden MG (2013) Allosteric regulation of PKM2 allows cellular adaptation to different physiological states. Sci Signal 6: pe7.
54. Leite TC, Coelho RG, Da Silva D, Coelho WS, Marinho-Carvalho MM, et al. (2010) Lactate downregulates the glycolytic enzymes hexokinase and phosphofructokinase in diverse tissues from mice. FEBS Lett 585: 92-98.
55. Costa Leite T, Da Silva D, Guimaraes Coelho R, Zancan P, Sola-Penna M (2007) Lactate favours the dissociation of skeletal muscle 6-phosphofructo-1- kinase tetramers down-regulating the enzyme and muscle glycolysis. Biochem J 408: 123-130. (Pubitemid 350158410)
56. Thorrez L, Van Deun K, Tranchevent LC, Van Lommel L, Engelen K, et al. (2008) Using ribosomal protein genes as reference: a tale of caution. PLoS One 3: e1854.
57. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, et al. (2006) TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126: 107-120. (Pubitemid 44040989)
58. Clem B, Telang S, Clem A, Yalcin A, Meier J, et al. (2008) Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther 7: 110-120.
59. Bandhakavi S, Kim YM, Ro SH, Xie H, Onsongo G, et al. (2010) Quantitative nuclear proteomics identifies mTOR regulation of DNA damage response. Mol Cell Proteomics 9: 403-414.
60. Park Y, Subramanian K, Verfaillie CM, Hu WS (2010) Expansion and hepatic differentiation of rat multipotent adult progenitor cells in microcarrier suspension culture. J Biotechnol 150: 131-139.
61. Wu C, Khan SA, Peng LJ, Lange AJ (2006) Roles for fructose-2,6- bisphosphate in the control of fuel metabolism: beyond its allosteric effects on glycolytic and gluconeogenic enzymes. Adv Enzyme Regul 46: 72-88. (Pubitemid 44301361)